Colorectal Cancer Trial, Recruiting NCT06714903 Sponsor: The First Hospital of Jilin University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06714903
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with colorectal cancer that has spread to other parts of the body (metastatic colorectal cancer), confirmed by both clinical assessment and laboratory/tissue analysis
  • People between the ages of 35 and 75 (including both ages)
  • People whose medical records and clinical information are complete
  • People who have signed a consent form agreeing to take part in the study

Who may not be able to join:

  • People who also have serious heart or lung conditions
  • People who have been diagnosed with another type of cancer in addition to colorectal cancer
  • People who have had recent serious active bleeding, an uncontrolled active infection, or an active stomach or intestinal ulcer
  • People with moderate to severe kidney problems
  • People whose situation the trial investigators determine to be unsuitable for participation for other reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nan Zhang, The First Hospital of Jilin University

Phone: 18686440802

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Hospital of Jilin University
Registry
ClinicalTrials.gov
Start date
15 July 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Evaluation of efficacy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov